secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K
Filed at:   2022-01-10T23:59:59+00:00
Accession:  0000950170-22-000156
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RxSight Q4 revenue ~$8.4M (+71% YoY); full year 2021 revenue ~$22.6M (+54% YoY)
-------------------------------------------------------------------------------

- Q4 2021 revenue ~$8.4M, up 71% YoY; sold 45 LDDs (installed base 206) and 2,959 LALs.
- FY 2021 revenue ~$22.6M, up 54% YoY; 114 LDDs and 8,328 LALs sold.
- Cash, equivalents and short-term investments ~$159.3M as of Dec 31, 2021.
- CEO Ron Kurtz cites continued adoption and ActivShield rollout as growth drivers for 2022.
- Results are preliminary; audited Q4 and FY 2021 results expected in early March.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000095017022000156/0000950170-22-000156-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000095017022000156/rxst-20220109.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-000156

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer